AmacaThera
AmacaThera is a hydrogel-based drug delivery founded in 2016 by Molly Shoichet.
3
Funding Rounds
$16.4m
Money raised
Overview
AmacaThera is a hydrogel-based drug delivery founded in 2016 by Molly Shoichet.
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Mo*** Sh****** | - | - | - |
| mi** co*** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| mi****** sc********* | - | - | - |
| lu ha* | - | - | - |
| mi** se******** | - | - | - |
| sa** se**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company AmacaThera has raised a total of $12.8m in funding over 3 rounds.
Key Insights:
- AmacaThera Series A round, February 22, 2021: $10.3m
- AmacaThera Seed round, January 2019: $2.5m
- AmacaThera funding round, October 2019: $3.6m
AmacaThera Series A round, February 22, 2021
$10.3m
AmacaThera Seed round, January 2019
$2.5m
AmacaThera funding round, October 2019
$3.6m
Industries
AmacaThera is active in the following industries: